These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [ON FRACTIONAL RADIOIODINE TREATMENT OF THYROTOXICOSIS]. FRIDRICH R; WALSER A Schweiz Med Wochenschr; 1965 Mar; 95():413-6. PubMed ID: 14277008 [No Abstract] [Full Text] [Related]
3. THERAPY OF THYROTOXICOSIS. DEGROOT LJ Mod Treat; 1964 Jan; 1():176-207. PubMed ID: 14161712 [No Abstract] [Full Text] [Related]
4. The treatment of toxic goitre (thyrotoxicosis). COOKSON H Practitioner; 1946 Nov; 157(941):399-401. PubMed ID: 21002623 [No Abstract] [Full Text] [Related]
5. [THYROTOXICOSIS WITHOUT HYPERSECRETION OF THYROXINE. A PRE-BASEDOW FORM]. KLOTZ HP; BITAN ; SAPORTA L Probl Actuels Endocrinol Nutr; 1964; 8():57-63. PubMed ID: 14265408 [No Abstract] [Full Text] [Related]
6. [ON THE THERAPEUTIC EFFECTIVENESS OF I-131 IN VARIOUS FORMS OF THYROTOXICOSIS]. LIVERGANT Ie; CHEBOTAREVA ED; TARKHANOVA MV Med Radiol (Mosk); 1963 Jul; 8():29-34. PubMed ID: 14079831 [No Abstract] [Full Text] [Related]
7. Thiouracil in the treatment of toxic goiter, and its dangers. DAVISON TC; LETTON AH J Med Assoc Ga; 1947 Mar; 36(3):112-6. PubMed ID: 20293040 [No Abstract] [Full Text] [Related]
8. [ON THE SIGNIFICANCE OF OCULAR SYMPTOMS IN THE TREATMENT OF THYROTOXICOSIS]. SHTULMAN DR Klin Med (Mosk); 1963 Jan; 41():83-92. PubMed ID: 14121334 [No Abstract] [Full Text] [Related]
9. Early occurrence of localized myxedema in a case of exophthalmic goiter treated with propylthiouracil. HANLEY MJ; HILL R; PHILIP AJ N Y State J Med; 1952 Jun; 52(11):1431-2. PubMed ID: 14941358 [No Abstract] [Full Text] [Related]
10. [RARE LATE COMPLICATIONS IN HYPERTHYROID PATIENTS TREATED WITH RADIOIODINATED I-131 ON BASIS OF MORE THAN 3500 CASES]. GENNARELLI L; LENTI R Minerva Med; 1964 Feb; 55():397-8. PubMed ID: 14139682 [No Abstract] [Full Text] [Related]
11. EFFECT OF THROXINE ON EXOPHTHALMOS IN THYROTOXICOSIS. KOUTRAS DA; ALEXANDER WD; BUCHANAN WW; HARDEN RM; HUNTER RD Br Med J; 1965 Feb; 1(5433):493-5. PubMed ID: 14238679 [No Abstract] [Full Text] [Related]
12. [DATA ON THE SU 4885 TEST IN BASEDOW'S DISEASE AND IN MYXEDEMA]. DECOURT J; JAYLE MF; MICHARD JP; FERRARI E; KELLY F Ann Endocrinol (Paris); 1963; 24():1023-9. PubMed ID: 14098077 [No Abstract] [Full Text] [Related]
13. [THYROID IODINE CLEARANCE. VALUE AND MEASUREMENT]. ROUX H; SOLSONA F; PAULIN R; CREVAT A J Radiol Electrol Med Nucl; 1964; 45():465-7. PubMed ID: 14200416 [No Abstract] [Full Text] [Related]
14. MANAGEMENT OF THYROTOXICOSIS IN PATIENTS WITH OPHTHALMOPATHY: ANTITHYROID REGIMEN DETERMINED PRIMARILY BY OCULAR MANIFESTATIONS. ARANOW H; DAY RM J Clin Endocrinol Metab; 1965 Jan; 25():1-10. PubMed ID: 14252283 [No Abstract] [Full Text] [Related]
15. [CURRENT VIEWS ON THE PATHOGENESIS OF OCULAR SYMPTOMS IN THYROTOXICOSIS]. STRIZHEVSKII AN Oftalmol Zh; 1964; 19():51-62. PubMed ID: 14149292 [No Abstract] [Full Text] [Related]
16. Toxic goiter and its conservative treatment. EISENLOHR E Med World (New York); 1946 Apr; 64():149-51. PubMed ID: 21024072 [No Abstract] [Full Text] [Related]
17. [LATE RESULTS OF RADIOIODINE THERAPY IN BASEDOW'S DISEASE]. FAZAKAS S; PETRANYI G Orv Hetil; 1964 May; 105():932-4. PubMed ID: 14159635 [No Abstract] [Full Text] [Related]
18. AFTER-EFFECTS OF THYROIDECTOMY. MURRAY JG Curr Med Drugs; 1963 May; 3(9):3-9. PubMed ID: 14087461 [No Abstract] [Full Text] [Related]
20. DIAGNOSTIC VALUE OF 131-I IN THYROID DISORDERS. A STUDY OF 649 PATIENTS. DYRBYE MO; PEITERSEN E; FRIIS T Acta Med Scand; 1964 Jul; 176():91-101. PubMed ID: 14194195 [No Abstract] [Full Text] [Related] [Next] [New Search]